Status: Not yet recruiting
A Study of SL-325 in Crohn's Disease Patients
The primary purpose of this study is to evaluate the efficacy of SL-325 in adult participants with moderate to severely active Crohn's disease. The study consists of a screening period of up to 6 weeks, a 12-week induction period, 38-week maintenance period, 52-week long-term extension period, and a 10-week follow-up period.
Participants needed: 232
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Shattuck Labs, Inc.Updated: Aug 12, 2026
Eligibility criteria
A diagnosis of Crohn's disease confirmed by endoscopy and histopathology ≥ 3 mon... [+3]
Diagnosis of UC, indeterminate colitis, or any other gastrointestinal condition... [+8]